Skip to main content
. 2021 Apr 24;36(5):559–564. doi: 10.1007/s10654-021-00743-7

Table 2.

Hazard ratios (95% confidence intervals) for the association of measures of baseline cognitive function (2006–2010) with death from COVID-19 (2020)

Adjusted for age, sex, and ethnicity Adjusted for age, sex, ethnicity, and comorbidity Adjusted for age, sex, ethnicity, and markers of socioeconomic status Adjusted for age, sex, ethnicity, and lifestyle factors Adjusted for age, sex, ethnicity, and biological factors Adjusted for all covariates
Verbal-numeric reasoning
Cases/Number at risk 125/180,198 123/177,361 90/145,975 119/177,545 77/126,190 58/101,731
1 (most disadvantaged) 2.04 (1.30, 3.20) 1.86 (1.18, 2.93) 2.22 (1.26, 3.94) 1.52 (0.95, 2.43) 2.32 (1.30, 4.14) 2.33 (1.16, 4.69)
2 1.35 (0.86, 2.14) 1.29 (0.81, 2.03) 1.34 (0.78, 231) 1.27 (0.80, 2.01) 1.62 (0.90, 1.89) 1.39 (0.73, 2.67)
3 1.0 (reference) 1.0 1.0 1.0 1.0 1.0
P for trend 0.002 0.007 0.006 0.082 0.004 0.019
Per SD disadvantage 1.32 (1.09, 1.59) 1.25 (1.04, 1.52) 1.31 (1.02, 1.67) 1.16 (0.96, 1.41) 1.29 (1.01, 1.64) 1.27 (0.94, 1.71)
Reaction time
Cases/Number at risk 388/494,932 378/483,785 182/339,977 373/484,832 250/352,096 122/243,954
1 1.0 (reference) 1.0 1.0 1.0 1.0 1.0
2 0.97 (0.73, 1.30) 0.92 (0.69, 1.24) 1.01 (0.67, 1.54) 0.94 (0.70, 1.27) 0.90 (0.62, 1.30) 0.84 (0.50, 1.43)
3 (most disadvantaged) 1.50 (1.15, 1.95) 1.40 (1.07, 1.83) 1.66 (1.13, 2.44) 1.35 (1.03, 1.77) 1.50 (1.08, 2.09) 1.75 (1.10, 2.77)
P for trend 0.001 0.003 0.004 0.009 0.003 0.006
Per SD disadvantage 1.18 (1.09, 1.28) 1.16 (1.07, 1.27) 1.21 (1.07, 1.37) 1.15 (1.06, 1.25) 1.19 (1.07, 1.31) 1.22 (1.04, 1.43)

Comorbidities: diagnoses of vascular or heart disease, diabetes, chronic bronchitis or emphysema, asthma, hypertension, and mental illness

Socioeconomic status (SES): educational attainment, occupational classification, and area deprivation. Lifestyle factors: body mass index, smoking status, alcohol intake, and physical activity. Biomarkers: Forced expiratory volume in the first second, and blood concentrations of C-reactive protein, glycated haemoglobin, and high-density lipoprotein